Citadel Advisors’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,047
| Closed | -$7.48K | – | 6614 |
|
|
2023
Q4 | $7.48K | Sell |
1,047
-1,386
| -57% | -$9.9K | ﹤0.01% | 5573 |
|
|
2023
Q3 | $38.3K | Buy |
+2,433
| New | +$38.3K | ﹤0.01% | 5162 |
|
|
2021
Q4 | – | Sell |
-47
| Closed | -$37K | – | 6912 |
|
|
2021
Q3 | $37K | Sell |
47
-28
| -37% | -$22K | ﹤0.01% | 6197 |
|
|
2021
Q2 | $62K | Buy |
75
+15
| +25% | +$12.4K | ﹤0.01% | 6139 |
|
|
2021
Q1 | $66K | Sell |
60
-6
| -9% | -$6.6K | ﹤0.01% | 6024 |
|
|
2020
Q4 | $57K | Buy |
66
+48
| +267% | +$41.5K | ﹤0.01% | 4831 |
|
|
2020
Q3 | $16K | Sell |
18
-16
| -47% | -$14.2K | ﹤0.01% | 4549 |
|
|
2020
Q2 | $47K | Buy |
+34
| New | +$47K | ﹤0.01% | 4390 |
|
|
2019
Q2 | – | Sell |
-10
| Closed | -$15K | – | 4938 |
|
|
2019
Q1 | $15K | Buy |
+10
| New | +$15K | ﹤0.01% | 4430 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$15K | – | 3934 |
|
|
2014
Q4 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 3710 |
|
|
2014
Q3 | – | Sell |
-1
| Closed | -$16K | – | 3664 |
|
|
2014
Q2 | $16K | Hold |
1
| – | – | ﹤0.01% | 3320 |
|
|
2014
Q1 | $23K | Hold |
1
| – | – | ﹤0.01% | 3443 |
|
|
2013
Q4 | $20K | Buy |
+1
| New | +$20K | ﹤0.01% | 2884 |
|
|
2013
Q3 | – | Sell |
-1
| Closed | -$23K | – | 3018 |
|
|
2013
Q2 | $23K | Buy |
+1
| New | +$23K | ﹤0.01% | 2619 |
|